|
|
专题讨论20：工作场所高血压管理
SYMPOSIUM 20: WORKSITE HYPERTENSION MANAGEMENT
|
Chairpersons: Arun Chockalingam (Canada),
George Fodor (Canada)
|
|
|
1.主题发言
Keynote: The worksite: a base for cardiovascular disease management
|
|
|
|
2.中欧工作场所高血压检测程序的经验介绍
Lessons learnt from worksite-based hypertension detection programs in central Europe
|
|
|
|
3.现实生活中的药物和高血压的治疗-从工地的研究和试验以及斯洛伐克人口的教训中学到的
Real-life medicine and therapy of hypertension - lessons from worksite studies and population trials from Slovakia
|
Jan Lietava, Bratislava (Slovak)
|
|
|
4.中国高血压与相关疾病的管理应以社区为基础进行长效管理-首钢的例子
It should be community-based and long-term intervention program to control the burden of hypertension and related diseases in China - an example in Shougang
|
|
|
|
|
|
|
|
|
|
专题讨论24：最新突破研究（1）
SYMPOSIUM 24: LATE BREAKING STUDIES (1)
|
Chairpersons: Dayi Hu (China),
Peter Meredith (UK)
|
|
|
|
|
|
|
2.硝苯地平控释片关于稳定性冠状动脉疾病的好处：对“行动”数据库进一步分析
Benefits of nifedipine GITS in stable coronary artery disease: further analysis of the "ACTION" database
|
|
|
|
|
|
|
|
4.Ontarget研究：中国的数据
Ontarget study: Chinese data
|
|
|
|
5.在原发性高血压患者中，用缬沙坦±氢氯噻嗪进行新治疗，通过Remind Cap®进行的多中心，随机，证明的概念，平行对照的研究
A multicenter, randomized, proof-of-concept, parallel-controlled study with Remind Cap® in patients with essential hypertension newly treated with valsartan ± hydrochlorothiazide
|
|
|
|
|
|
|
|
7.对中年对象的高正常血压或轻度高血压，将规则的盐与SmartSalt ®矿物盐交换在血压上的效果
The effect of replacing regular salt with SmartSalt® mineral salt on blood pressure in middle-aged subjects with high normal blood pressure or with mild hypertension
|
|
|
|
|
|
|
|
专题讨论26：肾素血管紧张素系统
SYMPOSIUM 26:RENIN-ANGIOTENSIN SYSTEM
|
Chairpersons: Hans Brunner (Switzerland),
Yuhua Dai (China)
|
|
|
1.RAAS的生理学回顾
Overview of the physiology of the RAAS
|
|
|
|
2.肾素受体的功能
Function of the (pro)renin receptor
|
Geneviève Nguyen (France)
|
|
|
3.除了ARBs外，我们对肾素抑制剂还有什么期待？
What to expect from renin inhibitors beyond ARBs?
|
|
|
|
4.RAS阻滞剂在糖尿病肾病中应用的复杂性
RAS inhibitor and atrial fibrillastion in hypertension: anti-inflammation or anti-hypertension
|
|
|
|
|
|
|
|
|
|
肾素血管紧张素系统（继续）
RENIN-ANGIOTENSIN SYSTEM(CONT’)
|
Chairpersons: Thomas Unger (Germany),
Dingliang Zhu (China)
|
|
|
6.正确选择RAS阻滞剂的剂量
Choosing the right dose for RAS-blockade
|
|
|
|
7.心血管医学中钾离子的重要性
Clinical importance of potassium in cardiovascular medicine
|
|
|
|
8.盐皮质激素，钾离子与实验性心血管重塑
Mineralocortico?d, potassium and experimental cardiovascular remodeling
|
|
|
|
9.肾素抑制剂的新发展
New development of renin inhibitors
|
|
|
|
10.醛固酮酶抑制剂的潜在价值
Potential use of aldosterone synthase inhibitors
|
Hans Brunner (Switzerland)
|
|
|
|
